JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNEILL, J. H.
Right arrow Articles by BRODY, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNEILL, J. H.
Right arrow Articles by BRODY, T. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 162, Issue 1, 121-133, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF VARIOUS DRUG PRETREATMENTS ON AMINE-INDUCED PHOSPHORYLASE ACTIVATION AND AMINE UPTAKE

JOHN H. McNEILL 1 and THEODORE M. BRODY 1

1 Department of Pharmacology, Michigan State University, East Lansing, Michigan

We have previously demonstrated that cocaine, phenindamine, tripelennamine, chlorpheniramine and promethazine will potentiate the effect of norepinephrine (NE) on cardiac phosphorylase a whereas triprolidine has no effect. In the present study, desipramine, imipramine, diphenhydramine, amitriptyline and methylphenidate were aLso found to enhance the effect of NE on phosphorylase a. All drugs which potentiated the NE effect were found to decrease the effect of tyramine on phosphorylase a and did not enhance the effect of isoproterenol. Triprolidine did not affect the response to either tyramine or isoproterenol. With the exception of promethazine all drugs which increased the response to norepinephrine and decreased the response to tyramine also decreased the uptake of both norepinephrine and tyramine. Triprolidine did not affect the uptake of either amine. The results are in agreement with the work of others that drugs which potentiate responses to norepinephrine will decrease responses to tyramine, presumably by blocking the active transport of both amines into adrenergic nerve terminals. The results also lend further support to the theory that tyramine utilizes the same uptake system as does norepinephrine. In addition it is concluded that some of the drugs used in the present study possess other pharmacologic actions in addition to blocking the uptake of amines.

Submitted on January 10, 1968
Accepted on March 7, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.